Saltar al contenido
Merck

Prednicarbate (dermatop): a review.

Journal of drugs in dermatology : JDD (2004-11-24)
Aditya K Gupta, Melody Chow
RESUMEN

Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflammatory skin diseases, for example atopic dermatitis. In the past, topical steroids have been a popular choice for treating these diseases; however, the potential for significant local and systemic adverse events, such as skin atrophy and hypothalamic-pituitary-adrenal (HPA) axis suppression have limited their use. Prednicarbate has been found to have a favorable benefit-risk ratio, with low skin atrophy potential, and a high anti-inflammatory action. Prednicarbate may be particularly advantageous when used intermittently in pediatric and elderly patients.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Prednicarbate for system suitability A, European Pharmacopoeia (EP) Reference Standard
Prednicarbate, European Pharmacopoeia (EP) Reference Standard